#Mdm2
In mice, deleting #Mdm2 in #osteocytes triggered cell death and increased bone formation. Dying osteocytes released vesicles rich in #TRPM8, a calcium channel. #Bone marrow stem cells took up these vesicles and were more likely to become bone-forming cells.👇
www.nature.com/articles/s41...
November 13, 2026 at 6:56 AM
No dia 07/11, foi ao ar mais um episódio do Strictly Come Dancing, na BBC, com Delta Goodrem (🇦🇺 Austrália 2026) dançando Cha Cha
www.youtube.com/watch?v=mdm2...
Delta Goodrem & Kai Cha Cha to Jennifer Lopez! ✨ BBC Strictly 2026
YouTube video by BBC Strictly Come Dancing
www.youtube.com
November 15, 2026 at 9:16 PM
We cover high-throughput screening, structural modeling, and generative design, with examples including KRAS, MDM2, and PD-L1. We also discuss the chemical modifications needed to improve properties such as stability and cell permeability.
October 27, 2026 at 3:58 PM
MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation https://pubmed.ncbi.nlm.nih.gov/42928021/
October 26, 2026 at 9:26 AM
Nanopore sensing with machine learning-assisted analysis for real-time single-molecule detection of MDM2-p53TAD interactions https://pubmed.ncbi.nlm.nih.gov/42832937/
October 19, 2026 at 10:12 AM
10/14/26: My hunch for RNAISH is that the ISHzyme had an issue. Need a manual ISHzyme treatment maybe better. Design a two-step process for this next time. There should be no problem with c-Myc from superior's block, but their liposarcoma is not good for MDM2.
October 14, 2026 at 11:28 PM
Nanopore sensing with machine learning-assisted analysis for real-time single-molecule detection of MDM2-p53TAD interactions https://pubmed.ncbi.nlm.nih.gov/42832937/
October 12, 2026 at 9:45 AM
The p53-Mdm2 interaction through the lens of antithetic feedback https://www.biorxiv.org/content/10.64898/2026.10.04.756583v1
October 6, 2026 at 10:02 AM
The p53-Mdm2 interaction through the lens of antithetic feedback https://www.biorxiv.org/content/10.64898/2026.10.04.756583v1
October 6, 2026 at 10:02 AM
Kaija Saariaho - ...à la fumée (1990) for alto flute, cello and large orchestra - YouTube
www.youtube.com/watch?v=MdM2...
Kaija Saariaho - ...à la fumée (1990) for alto flute, cello and large orchestra
YouTube video by Un petit abreuvoir
www.youtube.com
October 2, 2026 at 12:45 AM
NMR‐Guided Fragment Screening Identifies Privileged Noncanonical Amino Acids for mRNA Display
NMR‐Guided Fragment Screening Identifies Privileged Noncanonical Amino Acids for mRNA Display
A strategy is reported to prescreen and prioritize noncanonical amino acids as fragments prior to their use in mRNA display peptide libraries. Using MDM2 as a target, two ncAAs that bind to the Trp b...
chemistry-europe.onlinelibrary.wiley.com
October 1, 2026 at 12:35 AM
This is one (1) patient. But the symptoms, such as a primary left atrial intimal sarcoma, MDM2 amplification,
brain metastases, and death 675 days later, are consistent with genuine cardiac intimal sarcoma. That diagnosis happened 170 days after the first Pfizer dose is

2/9
September 29, 2026 at 11:41 AM
A new clinical trial is exploring SA53-OS, an MDM2 inhibitor, for people with advanced solid tumors, including #dedifferentiated #liposarcoma (#DDLPS). Learn more about this study, who may be eligible, and how the treatment is given.
clinicaltrials.gov/study/NCT065...
#ClinicalTrials #MDM2
September 28, 2026 at 4:13 PM


Integrative analysis of the MDM2 promoter switch and cellular lineage plasticity in colorectal cancer: a contrast between the autonomous-proliferation type (CIN/CMS2) and the environment-adaptive type (MSI/gastric metaplasia)

https://www.biorxiv.org/content/10.64898/2026.09.21.753357v1
September 28, 2026 at 12:17 PM
Integrative analysis of the MDM2 promoter switch and cellular lineage plasticity in colorectal cancer: a contrast between the autonomous-proliferation type (CIN/CMS2) and the environment-adaptive type (MSI/gastric metaplasia) https://www.biorxiv.org/content/10.64898/2026.09.21.753357v1
September 27, 2026 at 3:45 AM
Integrative analysis of the MDM2 promoter switch and cellular lineage plasticity in colorectal cancer: a contrast between the autonomous-proliferation type (CIN/CMS2) and the environment-adaptive type (MSI/gastric metaplasia) https://www.biorxiv.org/content/10.64898/2026.09.21.753357v1
September 27, 2026 at 3:45 AM
ipTM 0.28. A failed prediction?

LIVIA scores only the residue pairs AlphaFold is confident about, and finds the real p53–MDM2 interface: iLIS 0.663, past the 1% false-positive cutoff. Same model.
September 25, 2026 at 2:44 PM
“The expanding MDM2 universe”

Fresh off the press: an editorial by Prof. Engeland about the recently uncovered connection between MDM2 and #InnateImmunity ⤵️
nature.com/articles/s41...
The expanding MDM2 universe - Cell Death & Differentiation
Cell Death & Differentiation - The expanding MDM2 universe
nature.com
September 24, 2026 at 9:21 AM
"MDM2 binds and suppresses RNA polymerase III to restrain the innate immune response to cytosolic DNA"
www.nature.com/articles/s41...
MDM2 binds and suppresses RNA polymerase III to restrain the innate immune response to cytosolic DNA - Cell Death & Differentiation
Cell Death & Differentiation - MDM2 binds and suppresses RNA polymerase III to restrain the innate immune response to cytosolic DNA
www.nature.com
September 24, 2026 at 9:21 AM
COVID-19 mRNAワクチン接種後に発症した35歳男性における致死的な心臓内膜肉腫:腫瘍組織からSタンパク質をコードするプラスミドDNA断片が検出された
zenodo.org/records/2267...
「本症例報告は、mRNACOVID-19ワクチン接種から170日以内に、特定された腫瘍学的危険因子が一切ないにもかかわらず、極めて稀かつ侵襲性の高い心臓悪性腫瘍を発症した患者の腫瘍組織から、ワクチン由来のプラスミドDNA配列が検出されたことを記録したものである。mRNA COVID-19ワクチン接種は、この悪性腫瘍の潜在的な決定要因である可能性がある。」
生体から見つかるのは初では。
Fatal Cardiac Intimal Sarcoma in a 35-Year-Old Male Following COVID-19 mRNA Vaccination: Plasmid DNA Fragments Encoding the S-Protein Detected in Tumor Tissue
Abstract Background: Primary cardiac intimal sarcoma is an exceedingly rare and aggressive malignancy of the heart, characterized by poorly differentiated spindle-shaped cells, frequent MDM2 gene ampl...
zenodo.org
September 24, 2026 at 3:15 AM
【Ipsen、骨髄線維症のnavtemadlinを買収完了】
対象会社はKartos Therapeutics。navtemadlinは、ルキソリチニブで反応が足りない骨髄線維症への上乗せとして、第3相POIESISが走っている。買収完了の発表であり、第3相の成績発表ではない。
IpsenがKartos Therapeuticsの買収完了を発表──骨髄線維症薬navtemadlinで後期腫瘍領域パイプラインを強化
stellanews.life/financialres...
IpsenがKartos Therapeuticsの買収完了を発表──骨髄線維症薬navtemadlinで後期腫瘍領域パイプラインを強化
Ipsenは2026年8月21日、Kartos Therapeuticsの買収完了を発表した。第3相段階のMDM2阻害薬navtemadlinの獲得により、骨髄線維症領域の後期パイプラインを強化する。
stellanews.life
September 21, 2026 at 10:47 PM
【ASMR】ぞりぞり、こしょこしょ、ひゅーん
www.youtube.com/watch?v=mdM2...
[ASMR] Tapping and Scratching
YouTube video by Sakura Uno / Kemomimi-Refle!
www.youtube.com
September 10, 2026 at 4:09 PM
Atypical MDM2 p53 Regulation and Chemosensitivity Induced by Proximal PAS Deletion https://www.biorxiv.org/content/10.64898/2026.08.23.746494v1
August 24, 2026 at 10:46 PM